A RANDOMIZED, DOUBLE-BLIND PHASE 2B STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A 623 ADMINISTRATION IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2010
This article has no abstract
Epistemonikos ID: 487cf87bd8eadb8dc32870b13b20fa07b3b180d5
First added on: Apr 16, 2025